Indeed, in tamoxifen-resistant (TAMR) estrogen receptor-positive (ER+) breast cancer cells, HuR stabilizes ERBB2 mRNA, while miR-26a/b [59] inhibits its translation. Here, ERBB2 is linked to breast carcinoma.